Niacin and Carafate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Niacin (niacin) and Carafate (sucralfate). Common drug interactions include pericarditis lupus among females and myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Niacin and Carafate. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Niacin?

Niacin has active ingredients of niacin. It is often used in high blood cholesterol. eHealthMe is studying from 9,009 Niacin users. Check the latest studies of Niacin.

What is Carafate?

Carafate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 14,029 Carafate users. Check the latest studies of Carafate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

27 people who take Niacin and Carafate together, and have interactions are studied.

Niacin and Carafate drug interactions.

What are the common drug interactions of Niacin and Carafate, by gender? *:

female:

  1. Pericarditis lupus (inflammation of the pericardium with red ulcerations on the face)
  2. Pneumonia
  3. Suicide attempt
  4. Type 2 diabetes mellitus
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  7. Pyrexia (fever)
  8. Cardiac disorder
  9. Cardiac failure congestive
  10. Drug effect decreased

male:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Anger
  4. Angina pectoris (chest pain due to ischemia of the heart muscle)
  5. Anxiety
  6. Appendicitis (inflammation of the appendix)
  7. Arrhythmia (irregular heartbeat)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Back pain
  10. Balance disorder

What are the common drug interactions of Niacin and Carafate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Suicide attempt
  2. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  3. Frustration (a form of poorly expressed anger)
  4. Incontinence (lack of moderation or self-control)
  5. Urinary incontinence (inability to control the flow of urine and involuntary urination)

40-49:

n/a

50-59:

  1. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  2. Type 2 diabetes mellitus
  3. Balance disorder
  4. Chest pain
  5. Fall
  6. Fracture
  7. Hip fracture
  8. Peripheral vascular disorder
  9. Tooth extraction
  10. White blood cell count decreased

60+:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Anxiety
  5. Appendicitis (inflammation of the appendix)
  6. Arrhythmia (irregular heartbeat)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Back pain
  9. Benign prostatic hyperplasia (benign enlargement of the prostate)
  10. Blepharospasm (any abnormal contraction or twitch of the eyelid)

What are the existing conditions these people have? *

  1. Diabetes: 7 people, 25.93%
  2. Stable Angina (a constant chest pain): 5 people, 18.52%
  3. Osteoporosis (bones weak and more likely to break): 5 people, 18.52%
  4. Nausea (feeling of having an urge to vomit): 5 people, 18.52%
  5. Lung Cancer - Non-Small Cell (lung cancer): 5 people, 18.52%
  6. Glaucoma (increased fluid pressure in the eye with vision loss): 5 people, 18.52%
  7. Dyspnea (difficult or laboured breathing): 5 people, 18.52%
  8. Candidiasis (candidiasis or thrush is a fungal infection): 5 people, 18.52%
  9. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 14.81%
  10. Cystitis Interstitial (unknown cause characterized by bladder pain): 4 people, 14.81%

* Approximation only. Some reports may have incomplete information.

Do you take Niacin and Carafate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Niacin and Carafate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Niacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Carafate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Niacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carafate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on niacin and sucralfate (the active ingredients of Niacin and Carafate, respectively), and Niacin and Carafate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: